Abstract
The R-enantiomer of timolol, L-714,465, is considerably less potent as a beta 1- and beta 2-adrenoceptor antagonist in animals than timolol, whilst only slightly less potent in reducing intraocular pressure. If the same was true in man L-714,465 would have potential benefits over timolol in the treatment of glaucoma. The extent of bronchial beta-adrenoceptor blockade following one eyedrop in each eye of timolol 1% and L-714,465 1% was compared in six normal subjects, by measuring the displacement of the bronchodilator dose-response curve to isoprenaline following each drug compared to the isoprenaline dose-response curve after placebo eyedrops (methyl-cellulose). There was no significant difference between the dose-response curves to L-714,465 and placebo, but a significant displacement of the dose-response curve following timolol. The geometric mean dose ratio following timolol (21) differed significantly from that following L-714,465 (1.6). Heart rate at the end of the isoprenaline dose-response study was lower after timolol, despite the fact that subjects had received higher doses of isoprenaline. The trend was in the same direction after L-714,465 when compared with placebo though less marked. L-714,465 clearly causes less beta-adrenoceptor blockade than timolol when given as 1% eyedrops. The effects of L-714,465 1% on the airways and heart rate did not differ significantly from placebo in these six subjects but the pattern of response would be most consistent with L-714,465 having some beta-adrenoceptor blocking activity though considerably less than timolol.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Else O. F., Sorenson H., Edwards I. R. Plasma timolol levels after oral and intravenous administration. Eur J Clin Pharmacol. 1978 Dec 18;14(6):431–434. doi: 10.1007/BF00716385. [DOI] [PubMed] [Google Scholar]
- Fraunfelder F. T., Barker A. F. Respiratory effects of timolol. N Engl J Med. 1984 Nov 29;311(22):1441–1441. doi: 10.1056/nejm198411293112213. [DOI] [PubMed] [Google Scholar]
- Gribbin H. R., Baldwin C. J., Tattersfield A. E. Quantitative assessment of bronchial beta-adrenoceptor blockade in man. Br J Clin Pharmacol. 1979 Jun;7(6):551–556. doi: 10.1111/j.1365-2125.1979.tb04641.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gribbin H. R., Mackay A. D., Baldwin C. J., Tattersfield A. E. Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol. Br J Clin Pharmacol. 1981 Jul;12(1):61–65. doi: 10.1111/j.1365-2125.1981.tb01855.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones F. L., Ekberg N. L. Exacerbation of obstructive airway disease by timolol. JAMA. 1980 Dec 19;244(24):2730–2730. [PubMed] [Google Scholar]
- Kermode J. C., Edmonds C. J. Pathways of transepithelial potassium movement in the epithelium of distal colon in man. Clin Sci (Lond) 1980 Jul;59(1):29–39. doi: 10.1042/cs0590029. [DOI] [PubMed] [Google Scholar]
- Ostergaard Laursen S., Bjerrum P. Timolol eyedrop-induced severe bronchospasm. Acta Med Scand. 1982;211(6):505–506. doi: 10.1111/j.0954-6820.1982.tb01990.x. [DOI] [PubMed] [Google Scholar]
- Schoene R. B., Abuan T., Ward R. L., Beasley C. H. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Am J Ophthalmol. 1984 Jan;97(1):86–92. doi: 10.1016/0002-9394(84)90450-1. [DOI] [PubMed] [Google Scholar]
- Schoene R. B., Martin T. R., Charan N. B., French C. L. Timolol-induced bronchospasm in asthmatic bronchitis. JAMA. 1981 Apr 10;245(14):1460–1461. [PubMed] [Google Scholar]
- Tattersfield A. E., Cragg D. J., Bacon R. J. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man. Br J Clin Pharmacol. 1984 Sep;18(3):343–347. doi: 10.1111/j.1365-2125.1984.tb02474.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson T. W., Firor W. B., Johnson G. E., Holmes G. I., Tsianco M. C., Huber P. B., Davies R. O. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade. Clin Pharmacol Ther. 1982 Dec;32(6):676–685. doi: 10.1038/clpt.1982.223. [DOI] [PubMed] [Google Scholar]